Article Information
History
- September 4, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Tormod Rogne, MD PhD1,2,3,#,
- Kristin V Liyanarachi, MD1,4,^,
- Humaira Rasheed, PhD5,6,^,
- Laurent F Thomas, PhD5,7,8,9,
- Helene M Flatby, MSc1,3,
- Mari Løset, MD PhD5,10,
- Dipender Gill, BMBCh PhD11,12,
- Stephen Burgess, MMath PhD13,14,
- Cristen J Willer, PhD15,
- Kristian Hveem, MD PhD5,16,
- Bjørn O Åsvold, MD PhD17,5,
- Ben M Brumpton, MPH PhD5,6,18,
- Andrew T DeWan, MPH PhD2,1,
- Erik Solligård, MD PhD1,3,* and
- Jan K Damås, MD PhD1,19,4,*
- 1Gemini Center for Sepsis Research, Department of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
- 2Department of Chronic Disease Epidemiology and Center for Perinatal, Pediatric and Environmental Epidemiology, Yale School of Public Health, New Haven, CT, USA
- 3Clinic of Anaesthesia and Intensive Care, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
- 4Department of Infectious Diseases, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
- 5K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
- 6MRC Integrative Epidemiology Unit, University of Bristol, UK
- 7Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
- 8BioCore – Bioinformatics Core Facility, Norwegian University of Science and Technology, Trondheim. Norway
- 9Clinic of Laboratory Medicine, St.Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
- 10Department of Dermatology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
- 11Clinical Pharmacology and Therapeutics Section, Institute of Medical and Biomedical Education and Institute for Infection and Immunity, St George’s, University of London, London, UK
- 12Clinical Pharmacology Group, Pharmacy and Medicines Directorate, St George’s University Hospitals NHS Foundation Trust, London, UK
- 13MRC Biostatistics Unit, University of Cambridge, Cambridge, UK
- 14Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
- 15Department of Internal Medicine, Department of Human Genetics, Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA
- 16Department of Research, Innovation and Education, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
- 17Department of Endocrinology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
- 18Clinic of Thoracic and Occupational Medicine, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
- 19Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
- ↵#Corresponding author: Tormod Rogne Department of Circulation and Medical Imaging, NTNU Prinsesse Kristinas gate 3, Akutten og Hjerte-lunge-senteret, 3. etg Trondheim 7491, Norway Email: tormod.rogne{at}ntnu.no
↵^ Contributed equally
* Contributed equally
Posted September 04, 2020.
